|
PANK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8924419243358E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.89959159513364E-12 |
| Normal-vs-Stage2 |
2.11963779861435E-12 |
| Normal-vs-Stage3 |
1.6556755966235E-12 |
| Normal-vs-Stage4 |
3.79341003053923E-12 |
| Stage1-vs-Stage2 |
5.599200E-01 |
| Stage1-vs-Stage3 |
2.071000E-01 |
| Stage1-vs-Stage4 |
3.789000E-01 |
| Stage2-vs-Stage3 |
1.382200E-01 |
| Stage2-vs-Stage4 |
1.906580E-01 |
| Stage3-vs-Stage4 |
6.689400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89948057283118E-12 |
| Normal-vs-AfricanAmerican |
1.77891035235689E-12 |
| Normal-vs-Asian |
2.44879999999892E-05 |
| Caucasian-vs-AfricanAmerican |
4.727600E-01 |
| Caucasian-vs-Asian |
7.724600E-01 |
| AfricanAmerican-vs-Asian |
9.832000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.53352894219461E-13 |
| Normal-vs-Female |
2.0549117962787E-12 |
| Male-vs-Female |
1.078410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.17443857259059E-14 |
| Normal-vs-Extreme_Weight |
1.66944236212885E-12 |
| Normal-vs-Obese |
1.67754699020861E-13 |
| Normal-vs-Extreme_Obese |
3.362000E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.420000E-01 |
| Normal_Weight-vs-Obese |
6.151400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.510240E-01 |
| Extreme_Weight-vs-Obese |
2.822000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.624500E-02 |
| Obese-vs-Extreme_Obese |
1.881840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98538971321705E-13 |
| Normal-vs-Age(41-60Yrs) |
1.89293025698589E-13 |
| Normal-vs-Age(61-80Yrs) |
1.85651494177819E-12 |
| Normal-vs-Age(81-100Yrs) |
3.29836158385888E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.912000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.467800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.056200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.259800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.5812247025151E-14 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
5.46451772720502E-13 |
| Normal-VS-Unclassified PRCC |
1.97619698383278E-13 |
| Type1 PRCC-VS-Type2 PRCC |
3.436500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.418400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.318410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.437300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.601590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.999700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65234492754962E-12 |
| Normal-vs-N1 |
2.8199664825479E-14 |
| Normal-vs-N2 |
2.45169999999462E-05 |
| N0-vs-N1 |
6.789000E-01 |
| N0-vs-N2 |
2.250800E-01 |
| N1-vs-N2 |
3.751800E-01 |
|
|
